FACTOR VIII INHIBITOR ASSAY/ CITRATED PLASMA

image not found

NABL Cap Accredited    
The Factor VIII Inhibitor Assay by Metropolis Healthcare measures antibodies that inhibit Factor VIII activity in citrated plasma. These inhibitors can develop in patients with hemophilia A, leading to reduced clotting and increased bleeding risk. The test helps in diagnosing, monitoring, and guiding treatment strategies for affected individuals. Metropolis Healthcare provides accurate and reliable assessment using advanced coagulation techniques

  • 17 Crores+ Samples Processed
  • World Class Technology Labs
  • 25+ Years of Trust & Experience
  • Free Home Collection

Price: Rs. 10,400.00

Sample Type: CITRATED PLASMA

Fasting Not Required


Notes: F0122

Frequently Asked Questions (FAQ's):

What does the Factor VIII Inhibitor Assay measure?
It measures antibodies that inhibit Factor VIII activity, performed with Metropolis Healthcare’s precise coagulation methods.

Why is this test important?
It helps detect inhibitors in hemophilia A patients, which can affect clotting and treatment response.

What sample is required?
Citrated plasma is collected for the assay.

Who should take this test?
Patients with hemophilia A showing unexpected bleeding or poor response to Factor VIII therapy.

Is fasting required?
No fasting is required for this test.

How long do results take at Metropolis Healthcare?
Results are generally available within a few working days.

How do the results help?
They guide diagnosis, monitor inhibitor development, and assist in planning appropriate treatment strategies.

Can this test be repeated for monitoring?
Yes, Metropolis Healthcare can perform the test periodically to track inhibitor levels over time

OUR corporates PARTNER

Feedback

Patient's Testimonials

Trusted by Thousands

OUR Accreditations

OUR Lab